Showing results (301-310 of 326) with videos related to
Sort By:
Pageof 33
The New England Journal of Medicine|October 4, 1990
A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancerR O Dillman, S L Seagren, K J Propert, et al.Blood|November 15, 1991
A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group BR O Dillman, R B Davis, M R Green, et al.Lung Cancer (Amsterdam, Netherlands)|December 19, 1998
Analysis of neuroendocrine markers, HER2 and CEA before and after chemotherapy in patients with stage IIIA non-small cell lung cancer: a Cancer and Leukemia Group B studyS L Graziano, J A Kern, J E Herndon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II studyG M Strauss, J E Herndon, D D Sherman, et al.American Journal of Clinical Oncology|June 1, 1984
The treatment of melanoma with m-AMSA. A Cancer and Leukemia Group B phase II studyP C Amrein, R F Poulin, M Coleman, et al.Cancer|June 1, 1996
Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935P Kumar, J Herndon, M Langer, et al.Archives of Disease in Childhood|February 1, 1994
Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal periodL T Weaver, M R Green, K Nicholson, et al.Archives of Disease in Childhood|April 1, 1993
Cystic fibrosis identified by neonatal screening: incidence, genotype, and early natural historyM R Green, L T Weaver, A F Heeley, et al.Seminars in Oncology|December 10, 1999
Single-agent gemcitabine and gemcitabine/irinotecan combination (irimogem) in non-small cell lung cancerC M Rocha Lima, J R Eckardt, S S Leong, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
High-dose paclitaxel plus G-CSF for malignant mesothelioma: CALGB phase II study 9234N J Vogelzang, J E Herndon, A Miller, et al.Pageof 33